Aubagio ‘slows brain atrophy in RRMS patients’
Aubagio ‘slows brain atrophy in RRMS patients’
Genzyme has announced results from magnetic resonance imaging (MRI) analysis of participants in the Phase III TEMSO clinical trial showing Aubagio was able to slow the loss of brain volume (or atrophy) versus a placebo over two years in patients with relapsing-remitting multiple sclerosis (RRMS)... Read More - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 12111 Views
-
Last post by accordingnature495
-
- 0 Replies
- 1906 Views
-
Last post by NHE
-
- 0 Replies
- 1612 Views
-
Last post by NHE
-
- 4 Replies
- 1566 Views
-
Last post by NHE
-
- 0 Replies
- 1261 Views
-
Last post by NHE
-
- 0 Replies
- 1605 Views
-
Last post by NHE
-
- 0 Replies
- 2065 Views
-
Last post by frodo
-
- 0 Replies
- 2167 Views
-
Last post by NHE
-
- 0 Replies
- 1712 Views
-
Last post by NHE